Perinatal Flashcards
Risk of spontaneous malformation in pregnancy
2-3%
(Drugs account for 5%)
PMS treatment drugs
Severe PMS:
SSRIs/serotinergic TCA (response rate 60-90%)
Fluoxetine (appears most effective); sertraline; SNRI venlafaxine, clomipramine
Risk of depression in pregnancy
7-15% (10%) during
10% post-partum (higher in previous depression/bipolar)
Risk of post-partum psychosis (background)
1/1000 (0.1%)
Risk of post-partum psychosis previous episode
50-90%
Risk of postpartum psychosis:
- First degree family member, person no mental illness
- First degree family member and BPAD 1/schizoaffective
- Personal history, but no FH 1st pregnancy
- 3%
- 50%
- 20%
BPAD/schza and 2nd pregnancy (no postpartum 1st)
10% risk
Sodium valproate risk of neural tube defect
1/100 (1%)
Sodium valproate
Risk of any congential malformation
1/10 (10%)
40% of children may have a developmental disorder, including ASD (4%)
VSD, ASD
Spina bifida, anencephaly
Polydactyly, camptodactyly
Hypospadias
Background risk of
1. Miscarriage
2. Birth defects
- 10-20%
- 1/40 (2.5%)
Incidence of puerperal psychosis
1/1000
Most vulnerable period for foetal malformation
Weeks 6-10
Bipolar depression and delivery
5 fold increased risk of a relapse into depression after delivery
Risk of baby blues
50-70% resolves by day 14 post-partum
Ebstein abnormality risk
Background absolute risk: 1/20,000
1/10 chance if Lithium continued in 1st trimester
RR is 10-20× higher
Absolute risk low, 1:1000
Maximum risk 2-6 weeks
Extra scan 6-18 weeks
Lithium foetal toxicity; hypotonia, lethargy, resp difficulties, poor reflex, cardiac arrythmia